|
67
|
279
|
2hwoA |
Crystal structure of src kinase domain in complex with covalent inhibitor |
|
94
|
331
|
2i0eA |
Structure of catalytic domain of human protein kinase c beta ii complexed with a bisindolylmaleimide inhibitor |
|
93
|
293
|
2hy81 |
Pak1 complex with st2001 |
|
79
|
275
|
2hxqA |
Crystal structure of chek1 in complex with inhibitor 2 |
|
87
|
332
|
2if8A |
Crystal structure of inositol phosphate multikinase ipk2 in complex with adp and mn2+ from s. cerevisiae |
|
115
|
349
|
2i0hA |
The structure of p38alpha in complex with an arylpyridazinone |
|
80
|
297
|
2i40A |
Cdk2/cyclin a complexed with a thiophene carboxamide inhibitor |
|
76
|
320
|
2i0vA |
C-fms tyrosine kinase in complex with a quinolone inhibitor |
|
83
|
267
|
2hz4A |
Abl kinase domain unligated and in complex with tetrahydrostaurosporine |
|
79
|
275
|
2hxlA |
Crystal structure of chek1 in complex with inhibitor 1 |
|
83
|
335
|
2iewA |
Crystal structure of inositol phosphate multikinase ipk2 from s. cerevisiae |
|
95
|
320
|
2i1mA |
Cfms tyrosine kinase (tie2 kid) in complex with an arylamide inhibitor |
|
79
|
281
|
2henA |
Crystal structure of the ephb2 receptor kinase domain in complex with adp |
|
79
|
309
|
2i6lA |
Crystal structure of human mitogen activated protein kinase 6 (mapk6) |
|
80
|
279
|
2hogA |
Crystal structure of chek1 in complex with inhibitor 20 |
|
80
|
276
|
2helA |
Crystal structure of a mutant epha4 kinase domain (y742a) |
|
82
|
277
|
2hznA |
Abl kinase domain in complex with nvp-afg210 |
|
83
|
265
|
2hz0A |
Abl kinase domain in complex with nvp-aeg082 |
|
68
|
278
|
2hwpA |
Crystal structure of src kinase domain in complex with covalent inhibitor pd168393 |
|
77
|
274
|
2hiwA |
Crystal structure of inactive conformation abl kinase catalytic domain complexed with type ii inhibitor |
|
89
|
316
|
2i0yA |
Cfms tyrosine kinase (fgf kid) in complex with an arylamide inhibitor |
|
88
|
268
|
2hziA |
Abl kinase domain in complex with pd180970 |
|
79
|
279
|
2hy0A |
Crystal structure of chek1 in complex with inhibitor 22 |
|
85
|
302
|
2hw7A |
Crystal structure of mnk2-d228g in complex with staurosporine |
|
118
|
438
|
2hckA |
Src family kinase hck-quercetin complex |
|
100
|
317
|
2hakA |
Catalytic and ubiqutin-associated domains of mark1/par-1 |
|
79
|
297
|
2hw6A |
Crystal structure of mnk1 catalytic domain |
|
116
|
393
|
2h9vA |
Structural basis for induced-fit binding of rho-kinase to the inhibitor y27632 |
|
98
|
327
|
2gs6A |
Crystal structure of the active egfr kinase domain in complex with an atp analog-peptide conjugate |
|
95
|
358
|
2h96A |
Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-jun nh2-terminal kinase inhibitors |
|
105
|
337
|
2gu8A |
Discovery of 2-pyrimidyl-5-amidothiophenes as novel and potent inhibitors for akt: synthesis and sar studies |
|
92
|
323
|
2gs2A |
Crystal structure of the active egfr kinase domain |
|
86
|
269
|
2hk5A |
Hck kinase in complex with lck targetted inhibitor pg-1009247 |
|
138
|
445
|
2h8hA |
Src kinase in complex with a quinazoline inhibitor |
|
58
|
263
|
2h34A |
Apoenzyme crystal structure of the tuberculosis serine/threonine kinase, pkne |
|
74
|
310
|
2gs7A |
Crystal structure of the inactive egfr kinase domain in complex with amp-pnp |
|
105
|
348
|
2gtnA |
Mutated map kinase p38 (mus musculus) in complex with inhbitor pg-951717 |
|
80
|
278
|
2gqgA |
X-ray crystal structure of dasatinib (bms-354825) bound to activated abl kinase domain |
|
107
|
348
|
2gtmA |
Mutated mouse p38 map kinase domain in complex with inhibitor pg-892579 |
|
77
|
357
|
2gmxA |
Selective aminopyridine-based c-jun n-terminal kinase inhibitors with cellular activity |
|
76
|
269
|
2h6dA |
Protein kinase domain of the human 5'-amp-activated protein kinase catalytic subunit alpha-2 (ampk alpha-2 chain) |
|
91
|
310
|
2gsfA |
The human epha3 receptor tyrosine kinase and juxtamembrane region |
|
107
|
345
|
2gphA |
Docking motif interactions in the map kinase erk2 |
|
107
|
341
|
2gnfA |
Protein kinase a fivefold mutant model of rho-kinase with y-27632 |
|
108
|
340
|
2gniA |
Pka fivefold mutant model of rho-kinase with inhibitor fasudil (ha1077) |
|
101
|
348
|
2ghlA |
Mutant mus musculus p38 kinase domain in complex with inhibitor pg-874743 |
|
105
|
340
|
2gnhA |
Pka five fold mutant model of rho-kinase with h1152p |
|
106
|
340
|
2gnlA |
Pka threefold mutant model of rho-kinase with inhibitor h-1152p |
|
57
|
269
|
2ghgA |
H-chk1 complexed with a431994 |
|
96
|
309
|
2gcdA |
Tao2 kinase domain-staurosporine structure |
